Practical Guide to Building

The Sponsor Oversight Trifecta: Budget Intelligence, Risk-Based Monitoring, and Strategic Review for 2026

Executive summary In 2025, clinical trial success hinged less on protocol design and more on how sponsors managed oversight.  An updated analysis from the  Tufts Center for the Study of Drug Development estimates the average daily direct cost of a trial at $40,000 per day (Phase III:$55,716), indicating that fragmented oversight is no longer sustainable. The finalized […]

Learn More
Spotlight

Navigating 2025 and Beyond: 8 Forces Reshaping Clinical Development

Stay ahead of what’s next in clinical development. From regulatory insights and AI innovation to talent strategies and investor trends, this latest blog delivers actionable intelligence to help you navigate complexity, accelerate trials, and build a more resilient operation. Clinical development is entering its most consequential inflection point since ICH E6. The clinical development landscape […]

Learn More